Two high-growth stocks you might regret not buying

You could miss out on thousands of pounds of gains by overlooking these two companies.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Growth

Image: Public domain

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Over the past decade, RPC (LSE: RPC) has proven itself to be one of the market’s top growth champions. Indeed, if you’d invested in the business 10 years ago with £1,000, today that would be worth £4,431 today, including dividends. 

The plastic packaging maker has been able to achieve such impressive returns for investors as the business is highly profitable and cash generative. Management has been able to successfully reinvest that cash in acquisitions to help improve growth further. The largest of these deals was the recent $640m acquisition of US-based plastic food packaging manufacturer Letica Group, announced in February, which was at the time the sixth deal in five months. 

Growth through acquisitions 

These deals have paid off handsomely. Today, the group announced that during the six months to the end of September, revenue grew 53% year-on-year to £1.9bn, reflecting the contribution from acquisitions, and adjusted EBITDA rose 49%. Free cash flow was up 45% to £172m, from £118m the year before, giving management room to hike the interim payout by 28%. 

After a busy start to the year, RPC is now focused on optimising its cost structure, paying down debt and integrating existing acquisitions. According to management, there will be no further deals this year

Still, RPC does not need to buy to grow. Healthy cash generation gives the group plenty of scope to reinvest in the business and grow organically (management is also using cash to buy back stock). 

City analysts have pencilled in earnings per share growth of 11% for the fiscal year ending 31 March 2018, implying that the shares are trading at an estimated forward P/E of 13.4. I believe that this lowly valuation undervalues RPC and the group’s prospects considering the firm’s historical growth rate. The shares also support a dividend yield of 2.9%, and RPC has a 26-year record of increasing its payout to investors. 

Doubling profits 

Another growth stock I believe you might regret not buying is Quixant (LSE: QXT). 

Quixant is an exciting business. The firm manufactures specialist computer systems, which is proving to be highly lucrative. Earnings per share jumped 44% last year, and are on track to grow 36% this year, thanks to rising demand. 

In fact looking at the firm’s first-half results, I believe that the City’s estimate for growth of 36% for 2017 might be conservative. For the six months to 30 June, group revenue rose 38%, while EBITDA and pre-tax profit lept 74% and 98%, respectively. Management has cautioned that these strong growth numbers might not be repeated in the second half as H1 demand was “out of the ordinary” and such buoyant trading is unlikely to be repeated. Still, these numbers put the group in a great position to be able to hit full-year targets. 

The one downside with Quixant is that the shares are quite expensive. At the time of writing the stock is trading at a forward P/E of 29.9, although when you factor in the projected earnings growth for this year, the shares seem cheap, trading at a PEG ratio of 0.8.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves does not own any share mentioned. The Motley Fool UK has recommended RPC Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian man making doubtful face at camera
Investing Articles

Surprise! This monopoly stock has taken over my Stocks and Shares ISA (again)

Our writer has a (nice) dilemma in his Stocks and Shares ISA portfolio after one incredible growth stock rocketed higher…

Read more »

Investing Articles

10.5% yield – but could the abrdn share price get even cheaper?

Christopher Ruane sees some things to like about the current abrdn share price. But will that be enough to overcome…

Read more »

Investing Articles

£9,000 to invest? These 3 high-yield shares could deliver a £657 annual passive income

The high yields on these dividend shares sail sit well above the FTSE 100 average of 3.6%. Here's why I…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

I’ve got £2k and I’m on the hunt for cheap shares to buy in December

Harvey Jones finally has some cash in his trading account and is hunting for cheap shares to buy next month.…

Read more »

Investing Articles

Down 25% with a 4.32% yield and P/E of 8.6! Is this my best second income stock or worst?

Harvey Jones bought GSK shares hoping to bag a solid second income stream while nailing down steady share price growth…

Read more »

Investing Articles

Here’s how the Legal & General dividend yield could ultimately hit 15%!

The Legal & General dividend yield is already among the best of any FTSE 100 share. Christopher Ruane explores some…

Read more »

Investing Articles

Is December a good time for me to buy UK shares?

This writer is weighing up which shares to buy for his portfolio next month, and one household name from the…

Read more »

Investing Articles

Is it time to dump my Lloyds shares and never look back?

Harvey Jones was chuffed with his Lloyds shares but recent events have made him rethink his entire decision to go…

Read more »